Focus on HIV Care

Back to articles

Similar efficacy with atazanavir/ritonavir versus efavirenz in initial HIV-1 regimen

KEY POINT

For initial treatment of HIV-1 infection, atazanavir (Reyataz—Bristol-Myers Squibb) plus ritonavir (Norvir—Abbott Laboratories) provides antiviral activity similar to efavirenz (Sustiva—Bristol-Myers Squibb) when used with abacavir/lamivudine (Epzicom—GlaxoSmithKline) or tenofovir disoproxil fumarate (DF)/emtricitabine (Truvada—Gilead).